ATH 0.00% 0.4¢ alterity therapeutics limited

I desperately want PBT2 to be a success but this US analyst...

  1. 221 Posts.
    lightbulb Created with Sketch. 90
    I desperately want PBT2 to be a success but this US analyst can't just be dismissed as a shorter. He makes some valid points.

    There were several Executive Function tests undertaken - Fluency Test, Trail Marking A, Trail Marking B, Map Search, Symbol Digit, Modalities and Stroop Word Ready. It was only the Trail Marking B that showed statistically significant improvement. The average of all scores showed no statistically significant change.

    Perhaps someone with expertise in the area can explain why having no change amongst an average for all the tests, but a good result for one, is grounds to say there was cognitive improvement.

    I want this analyst to be wrong but playing the man and not the issues he raises is not going to help. Unfortunately there is no opportunity for questions in tomorrows conference call, so hoping someone can answer this.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $886 275.3K

Buyers (Bids)

No. Vol. Price($)
48 56368671 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 125986200 26
View Market Depth
Last trade - 11.34am 30/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.